Mokuolu O, Ambrose G, Mohammed Baba Abdulkadir , Ibrahim S, Funsho I, Mokuolu T
Curr Res Microb Sci. 2024; 7:100304.
PMID: 39534723
PMC: 11554628.
DOI: 10.1016/j.crmicr.2024.100304.
Alruwaili M, Elahi R, van Schalkwyk D, Sutherland C, Shapiro T, Prigge S
Am J Trop Med Hyg. 2023; 108(4):777-782.
PMID: 36878214
PMC: 10077009.
DOI: 10.4269/ajtmh.22-0700.
Hassen J, Alemayehu G, Dinka H, Golassa L
Malar J. 2022; 21(1):286.
PMID: 36207750
PMC: 9547420.
DOI: 10.1186/s12936-022-04304-5.
Silva M, Malmberg M, Otienoburu S, Bjorkman A, Ngasala B, Martensson A
Front Pharmacol. 2022; 13:868723.
PMID: 35685627
PMC: 9171324.
DOI: 10.3389/fphar.2022.868723.
Chen Y, Shiu T, Tseng L, Cheng C, Shih W, de Assuncao Carvalho A
Malar J. 2021; 20(1):467.
PMID: 34906134
PMC: 8672503.
DOI: 10.1186/s12936-021-04007-3.
Stable high frequencies of sulfadoxine-pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine-pyrimethamine in Ujjain, Madhya Pradesh,....
Pathak A, Martensson A, Gawariker S, Sharma A, Diwan V, Purohit M
Malar J. 2020; 19(1):290.
PMID: 32795288
PMC: 7427725.
DOI: 10.1186/s12936-020-03274-w.
Parasite clearance, cure rate, post-treatment prophylaxis and safety of standard 3-day versus an extended 6-day treatment of artemether-lumefantrine and a single low-dose primaquine for uncomplicated Plasmodium falciparum malaria in Bagamoyo....
Mhamilawa L, Ngasala B, Morris U, Kitabi E, Barnes R, Soe A
Malar J. 2020; 19(1):216.
PMID: 32576258
PMC: 7310382.
DOI: 10.1186/s12936-020-03287-5.
Prevalence of Plasmodium falciparum Pfcrt and Pfmdr1 alleles in settings with different levels of Plasmodium vivax co-endemicity in Ethiopia.
Hailemeskel E, Menberu T, Shumie G, Behaksra S, Chali W, Keffale M
Int J Parasitol Drugs Drug Resist. 2019; 11:8-12.
PMID: 31539706
PMC: 6796752.
DOI: 10.1016/j.ijpddr.2019.09.002.
Evidence of Self-Medication with Chloroquine before Consultation for Malaria in the Southern Pacific Coast Region of Colombia.
Diaz G, Lasso A, Murillo C, Montenegro L, Echeverry D
Am J Trop Med Hyg. 2018; 100(1):66-71.
PMID: 30457089
PMC: 6335913.
DOI: 10.4269/ajtmh.18-0515.
Molecular analysis demonstrates high prevalence of chloroquine resistance but no evidence of artemisinin resistance in Plasmodium falciparum in the Chittagong Hill Tracts of Bangladesh.
Alam M, Ley B, Nima M, Johora F, Hossain M, Thriemer K
Malar J. 2017; 16(1):335.
PMID: 28806961
PMC: 5557264.
DOI: 10.1186/s12936-017-1995-5.
Unexpected selections of Plasmodium falciparum polymorphisms in previously treatment-naïve areas after monthly presumptive administration of three different anti-malarial drugs in Liberia 1976-78.
Jovel I, Bjorkman A, Roper C, Martensson A, Ursing J
Malar J. 2017; 16(1):113.
PMID: 28288632
PMC: 5347173.
DOI: 10.1186/s12936-017-1747-6.
MOLECULAR SURVEILLANCE OF Plasmodium vivax AND Plasmodium falciparum DHFR MUTATIONS IN ISOLATES FROM SOUTHERN IRAN.
Sharifi-Sarasiabi K, Haghighi A, Kazemi B, Taghipour N, Nazemalhosseini Mojarad E, Gachkar L
Rev Inst Med Trop Sao Paulo. 2016; 58:16.
PMID: 27007559
PMC: 4804553.
DOI: 10.1590/S1678-9946201658016.
Temporal and seasonal changes of genetic polymorphisms associated with altered drug susceptibility to chloroquine, lumefantrine, and quinine in Guinea-Bissau between 2003 and 2012.
Jovel I, Kofoed P, Rombo L, Rodrigues A, Ursing J
Antimicrob Agents Chemother. 2014; 59(2):872-9.
PMID: 25421474
PMC: 4335894.
DOI: 10.1128/AAC.03554-14.
Characterization of drug resistance associated genetic polymorphisms among Plasmodium falciparum field isolates in Ujjain, Madhya Pradesh, India.
Pathak A, Martensson A, Gawariker S, Mandliya J, Sharma A, Diwan V
Malar J. 2014; 13:182.
PMID: 24885535
PMC: 4036110.
DOI: 10.1186/1475-2875-13-182.
The usefulness of rapid diagnostic tests in the new context of low malaria transmission in Zanzibar.
Shakely D, Elfving K, Aydin-Schmidt B, Msellem M, Morris U, Omar R
PLoS One. 2013; 8(9):e72912.
PMID: 24023791
PMC: 3762850.
DOI: 10.1371/journal.pone.0072912.
Rapid diagnostic tests for molecular surveillance of Plasmodium falciparum malaria -assessment of DNA extraction methods and field applicability.
Morris U, Aydin-Schmidt B, Shakely D, Martensson A, Jornhagen L, Ali A
Malar J. 2013; 12:106.
PMID: 23510231
PMC: 3605315.
DOI: 10.1186/1475-2875-12-106.
Temporal trends of molecular markers associated with artemether-lumefantrine tolerance/resistance in Bagamoyo district, Tanzania.
Malmberg M, Ngasala B, Ferreira P, Larsson E, Jovel I, Hjalmarsson A
Malar J. 2013; 12:103.
PMID: 23506218
PMC: 3732084.
DOI: 10.1186/1475-2875-12-103.
Decreased prevalence of Plasmodium falciparum resistance markers to amodiaquine despite its wide scale use as ACT partner drug in Zanzibar.
Froberg G, Jornhagen L, Morris U, Shakely D, Msellem M, Gil J
Malar J. 2012; 11:321.
PMID: 22966778
PMC: 3468380.
DOI: 10.1186/1475-2875-11-321.
Drug resistance associated genetic polymorphisms in Plasmodium falciparum and Plasmodium vivax collected in Honduras, Central America.
Jovel I, Mejia R, Banegas E, Piedade R, Alger J, Fontecha G
Malar J. 2011; 10:376.
PMID: 22183028
PMC: 3266654.
DOI: 10.1186/1475-2875-10-376.
Paracetamol versus placebo in treatment of non-severe malaria in children in Guinea-Bissau: a randomized controlled trial.
Kofoed P, Ursing J, Rodrigues A, Rombo L
Malar J. 2011; 10:148.
PMID: 21631932
PMC: 3123603.
DOI: 10.1186/1475-2875-10-148.
